Neogen Corporation
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2022 | 2023 | 2024 | 2025 | 2026 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 527.16M | 822.45M | 924.22M | 894.66M | 870.40M | -2.7% | |
| Cost of Revenue | (284.15M) | (416.49M) | (461.59M) | (473.29M) | (461.90M) | -2.4% | |
Gross Profit | 243.01M | 405.95M | 462.63M | 421.38M | 408.50M | -3.1% | |
| Operating Expenses | |||||||
| Research & Development | (17.05M) | (26.04M) | (22.48M) | (21.09M) | (18.40M) | -12.7% | |
| Selling, General & Administrative | (167.35M) | (342.40M) | (382.76M) | (401.96M) | (411.70M) | 2.4% | |
| General & Administrative | (82.74M) | (201.18M) | (199.89M) | (218.17M) | (245.10M) | 12.3% | |
| Selling & Marketing | (84.60M) | (141.22M) | (182.87M) | (183.80M) | (166.60M) | -9.4% | |
| Depreciation & Amortization | (23.69M) | (88.38M) | (121.23M) | (125.67M) | (121.90M) | -3.0% | |
Operating Income (EBIT) | 58.62M | 37.52M | 77.43M | 9.42M | -21.60M | -329.3% | |
| Non-Operating Items | |||||||
| Interest Income | 1.34M | 3.17M | 6.36M | 3.11M | — | -100.0% | |
| Interest Expense | (72.00K) | (55.96M) | (73.39M) | (71.62M) | (57.60M) | -19.6% | |
| Other Income/Expenses (Net) | 1.59M | -59.56M | -91.73M | -1.14B | 12.60M | -101.1% | |
Income Before Tax | 60.21M | -22.04M | -14.30M | -1.13B | -9.00M | -99.2% | |
| Income Tax Expense | (11.90M) | (828.00K) | (4.88M) | (41.07M) | (1.10M) | -97.3% | |
Net Income | 48.31M | -22.87M | -9.42M | -1.09B | -7.90M | -99.3% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $0 | $-0 | $-0 | $-5 | $-0 | -99.2% | |
| Weighted Avg Shares Outstanding | 107.68M | 188.88M | 216.48M | 216.89M | 217.50M | 0.3% | |
| Weighted Avg Shares Outstanding (Diluted) | 108.02M | 188.88M | 216.48M | 216.89M | 217.50M | 0.3% | |
EBITDA | 83.90M | 122.30M | 182.60M | -937.75M | 170.50M | -118.2% |
Explore NEOG
NEOG in the Healthcare
Mid Cap